Kidneys in Common – Trademark Portfolio
Entity Type: 99
Kidneys in Common holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 6 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include KIDNEYS IN COMMON, KIDNEYS FOR CHILDREN, KIDNEYS FOR COMMUNITIES, COMMUNITY-DIRECTED DONATION, and KIDNEYS FOR FIRST RESPONDERS. The owner is based in Holland, OH.
PO Box 707
Holland, OH 43528
Showing of trademarks Trademarks
Trademark Classifications
Kidneys in Common's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does Kidneys in Common have?
Kidneys in Common has 6 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 abandoned.
What trademark classes does Kidneys in Common file in?
Kidneys in Common files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 36 (Insurance & Financial). Class 35 covers advertising; business management; business administration; office functions.
What are Kidneys in Common's most well-known trademarks?
Kidneys in Common's registered trademark portfolio includes well-known marks such as KIDNEYS IN COMMON, KIDNEYS FOR CHILDREN, KIDNEYS FOR COMMUNITIES, COMMUNITY-DIRECTED DONATION, and KIDNEYS FOR FIRST RESPONDERS. These are among 5 currently registered trademarks in the portfolio.
What is Kidneys in Common's trademark registration success rate?
Kidneys in Common has a 83% trademark registration rate, with 5 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.